AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.

Barclays’ profits rose by one-third in the second quarter, as the lender hit the halfway point of a three-year plan to revamp its operations and reduce reliance on its investment bank. The British ...